Novo Nordisk Q2 2026 adjusted operating profit rises 11% to DKK 33.39 billion; adjusted sales increase 7% to DKK 78.49 billion - NVO News | RalliesNovo Nordisk Q2 2026 adjusted operating profit rises 11% to DKK 33.39 billion; adjusted sales increase 7% to DKK 78.49 billion
N
NVO• Q2 results and updated outlook
- Novo Nordisk posted Q2 2026 adjusted sales of DKK 78.49 billion, up 7% from a year earlier.
- Adjusted operating profit rose 11% to DKK 33.39 billion.
- The company raised its 2026 outlook for adjusted sales growth to 0% to -6% from -4% to -12%.
- It also lifted its adjusted operating profit growth view to 0% to -6% from -4% to -12%, citing higher expectations for GLP-1 product sales.
